University of California, Irvine - Chao Family Comprehensive Cancer Center
Orange, California 92868
1 studies enrolling now · 9 studies all time
What they study most
Advanced Solid Tumors, Advanced or Metastatic Gastric Cancer, Advanced or Metastatic Gastroesophageal Junction Cancer, Anemia, Cytokine Release Syndrome, Glioblastoma, Glioma, Gliosarcoma, KEAP1 Gene Mutation, Lymphopenia, NFE2L2 Gene Mutation, NRF2 Gene Mutation
Studies at this site
- Study of CTO1681 for the Prevention and Treatment of CRS in DLBCL Patients Receiving CAR T-Cell Therapy — Recruiting now
- Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer — Recruiting now
- Adjuvant Avelumab in Merkel Cell Cancer — Running, not enrolling
- A Study of MRG002 in Patients with HER2-Positive Advanced Solid Tumors and Locally Advanced or Metastatic Gastric/Gastroesophageal Junction (GEJ) Cancer — Running, not enrolling
- KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLC — Stopped early
- Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma — Stopped early
- Expanded Access For Lorlatinib For Patients With Non Small Cell Lung Cancer ALK Positive or ROS1 Positive — NO_LONGER_AVAILABLE
- Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer — Completed
- Neuropathic Pain in Patients With Cancer — Completed